Thank you very much, Mr. Chair.
I'll thank the minister and the officials for being here with us this evening. It's getting quite late.
I really appreciate this conversation. I appreciate it for many reasons, I think predominantly because the worst of the pandemic is in the rearview mirror. We learned so many lessons over this very difficult time. I've had hundreds of conversations with constituents about this time and the ongoing impacts we're still feeling in the community. We've talked about some of the fears and the misinformation. We've talked about procurement. We've talked about our ability to respond in the future as well.
I'm often asked about our internal capacity or domestic capacity around vaccine production. I know that the Auditor General's report on COVID-19 vaccines indicated that Canada had very limited domestic capacity to produce vaccines and, therefore, was reliant on international imported products.
Why was this?